Wolfgang A. Schmalix
- Molecular Biology
- Cancer Research top 10%
- Pharmacology top 2%
- Oncology
- Physiology
- Co-authors
- Johannes DoehmerWolfhard BandlowHelmut GreimJ. StadlerT. BrillJ. R. SiewertViktor MagdolenManfred Schmitt
- Topics
- Pharmacogenetics and Drug Metabolism (9 papers)Protease and Inhibitor Mechanisms (8 papers)Peptidase Inhibition and Analysis (7 papers)
- Partner nations
- GermanyNetherlandsIndia
In The Last Decade
Wolfgang A. Schmalix
35 papers receiving 985 citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 464
- Cancer Research 275
- Pharmacology 215
- Oncology 172
- Physiology 123
Countries citing papers authored by Wolfgang A. Schmalix
This map shows the geographic impact of Wolfgang A. Schmalix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang A. Schmalix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang A. Schmalix more than expected).
Fields of papers citing papers by Wolfgang A. Schmalix
This network shows the impact of papers produced by Wolfgang A. Schmalix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang A. Schmalix. The network helps show where Wolfgang A. Schmalix may publish in the future.
Co-authorship network of co-authors of Wolfgang A. Schmalix
This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang A. Schmalix. A scholar is included among the top collaborators of Wolfgang A. Schmalix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang A. Schmalix. Wolfgang A. Schmalix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 22 | |
| 3 | 7 | |
| 4 | 33 | |
| 5 | 7 | |
| 6 | 6 | |
| 7 | 23 | |
| 8 | 48 | |
| 9 | 67 | |
| 10 | 69 | |
| 11 | 9 | |
| 12 | 27 | |
| 13 | 41 | |
| 14 | 4 | |
| 15 | 44 | |
| 16 | 12 | |
| 17 | 6 | |
| 18 | 38 | |
| 19 | 24 | |
| 20 | 32 |
About Wolfgang A. Schmalix
Wolfgang A. Schmalix is a scholar working on Pharmacology, Cancer Research and Biochemistry, having authored 35 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (9 papers), Protease and Inhibitor Mechanisms (8 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Pharmacology (215 citations), Cancer Research (275 citations) and Biochemistry (123 citations). Wolfgang A. Schmalix has collaborated with scholars based in Germany, Netherlands and India. Frequent co-authors include Johannes Doehmer, Wolfhard Bandlow, Helmut Greim, J. Stadler, T. Brill, J. R. Siewert, Viktor Magdolen, Manfred Schmitt, Bernd Muehlenweg and Buddy Setyono-Han. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.